Internal Medicine, Medical Oncology · New York, NY
NPI
1295833937
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
161 Fort Washington Avenue, Room 936
New York, NY, 10032
Phone (212) 305-8230
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,004 services
Medicare patients, 2024
89
Average age 77
Drug cost, 2024
$1.1M
175 prescriptions
Company payments, 2024
$5,657
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark B Stoopler was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 306 times for 78 patients. In total Mark B Stoopler billed 1,004 services in 10 codes, and Medicare paid $71K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 306 | 78 | $15.62 | $4,780 |
| 99215 Office E&M - Established | Office | 205 | 50 | $170.09 | $35K |
| 99214 Office E&M - Established | Office | 201 | 73 | $113.43 | $23K |
| 36415 Venipuncture Blood Collection | Office | 193 | 47 | $8.65 | $1,669 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 40 | 16 | $31.30 | $1,252 |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 11 | $112.40 | $3,035 |
| 99213 Office E&M - Established | Office | 19 | 12 | $52.46 | $997 |
By year: 2022 $87K for 1,047 services; 2023 $84K for 939 services; 2024 $71K for 1,004 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 193 | 47 | $8.65 | $1,669 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark B Stoopler prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 48 prescriptions and refills. In total Mark B Stoopler wrote 175 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 48 | 48 | Under 11 | $799K |
| Erlotinib Hcl Generic | 40 | 42 | Under 11 | $157K |
| Xarelto Rivaroxaban | 12 | 16 | Under 11 | $8,780 |
| Gilotrif Afatinib Dimaleate | 11 | 11 | Under 11 | $122K |
Brand drugs: 76 claims; generic drugs: 99 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark B Stoopler $5,657 ($5,657 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $5,657.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $5,657 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.